KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 161 filers reported holding KARUNA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.69 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $111,769 | -80.9% | 661 | -75.6% | 0.00% | -100.0% |
Q2 2023 | $586,579 | +11.4% | 2,705 | -6.7% | 0.00% | 0.0% |
Q1 2023 | $526,574 | -25.6% | 2,899 | -19.6% | 0.00% | 0.0% |
Q4 2022 | $708,186 | -12.2% | 3,604 | +0.5% | 0.00% | -50.0% |
Q3 2022 | $807,000 | +45.7% | 3,585 | -18.2% | 0.00% | +100.0% |
Q2 2022 | $554,000 | +601.3% | 4,382 | +606.8% | 0.00% | – |
Q1 2022 | $79,000 | +3.9% | 620 | +6.9% | 0.00% | – |
Q4 2021 | $76,000 | +7.0% | 580 | 0.0% | 0.00% | – |
Q3 2021 | $71,000 | -21.1% | 580 | -26.1% | 0.00% | – |
Q2 2021 | $90,000 | -68.3% | 785 | -66.8% | 0.00% | -100.0% |
Q1 2021 | $284,000 | -32.2% | 2,365 | -42.6% | 0.00% | 0.0% |
Q4 2020 | $419,000 | -1.4% | 4,121 | -25.0% | 0.00% | 0.0% |
Q3 2020 | $425,000 | +193.1% | 5,496 | +323.4% | 0.00% | – |
Q2 2020 | $145,000 | +90.8% | 1,298 | +23.7% | 0.00% | – |
Q1 2020 | $76,000 | +162.1% | 1,049 | +172.5% | 0.00% | – |
Q4 2019 | $29,000 | – | 385 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $169,578,435 | 55.90% |
Nan Fung Group Holdings Ltd | 225,688 | $48,940,443 | 31.28% |
Sofinnova Investments, Inc. | 1,381,149 | $299,502,161 | 19.62% |
Paradigm Biocapital Advisors LP | 283,605 | $61,499,744 | 4.75% |
First Light Asset Management, LLC | 208,746 | $45,266,570 | 3.55% |
Avidity Partners Management LP | 442,200 | $95,891,070 | 3.35% |
CATALYST PRIVATE WEALTH, LLC | 21,837 | $4,735,353 | 2.97% |
Rock Springs Capital Management LP | 493,527 | $107,021,330 | 2.55% |
Boxer Capital, LLC | 250,000 | $54,213 | 2.51% |
DAFNA Capital Management LLC | 42,173 | $9,145,215 | 2.50% |